Statistical considerations in biosimilar clinical efficacy trials with asymmetrical margins
Crossref DOI link: https://doi.org/10.1002/sim.5612
Published Online: 2012-09-18
Published Print: 2013-02-10
Update policy: https://doi.org/10.1002/crossmark_policy
Li, Yulan
Liu, Qing
Wood, Patricia
Johri, Anandhi
Version of Record valid from 2012-09-18
Text and Data Mining valid from 2012-09-18